sk&f 99085 has been researched along with farnesol in 1 studies
Studies (sk&f 99085) | Trials (sk&f 99085) | Recent Studies (post-2010) (sk&f 99085) | Studies (farnesol) | Trials (farnesol) | Recent Studies (post-2010) (farnesol) |
---|---|---|---|---|---|
15 | 2 | 3 | 1,161 | 9 | 404 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antoni, I; Bentzen, CL; Flach, J; Niesor, EJ; Villemin, P | 1 |
1 other study(ies) available for sk&f 99085 and farnesol
Article | Year |
---|---|
The mevalonate/isoprenoid pathway inhibitor apomine (SR-45023A) is antiproliferative and induces apoptosis similar to farnesol.
Topics: Anticholesteremic Agents; Antineoplastic Agents; Apoptosis; Cell Division; Diphosphonates; Dose-Response Relationship, Drug; Farnesol; Humans; Hydroxycholesterols; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Molecular Mimicry; Simvastatin; Terpenes; Tumor Cells, Cultured | 2000 |